We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pozen Sues Par Pharmaceutical Over Migraine ANDA

Law360 (November 17, 2008, 12:00 AM EST) -- Pozen Inc., a North Carolina-based pharmaceutical company specializing in pain medication, has sued Par Pharmaceutical Inc., for seeking regulatory approval of a generic version of Pozen's patented migraine treatment Treximet....
To view the full article, register now.